Evidence Hub

Use of a Hysteroscopic Tissue Removal System for Revision of Cesarean Scar Isthmocele: A Case Report

Shahryar K. Kavoussi, Amy S Esqueda, Krista London, S. Compton, Ellen Jatinen, Kelsey Cathcart

Case Reports in Obstetrics and Gynecology, 2025

Abstract

Cesarean scar isthmocele (CSI) is a defect in the anterior myometrial wall of the uterine isthmus, at the site of a previous cesarean scar, and can be associated with menorrhagia in the form of prolonged menstrual bleeding or spotting, dysmenorrhea, and/or secondary subfertility. We report a case of hysteroscopic morcellation of CSI with a subsequent successful pregnancy. A 37‐year‐old female with menorrhagia since cesarean delivery and secondary subfertility, with midcycle transvaginal sonogram (TVS) showing a CSI with associated endometrial cavity fluid (ECF) as well as a small endometrial polyp, underwent hysteroscopic revision of the CSI and polypectomy via a tissue removal system. Postoperatively, menorrhagia had resolved, and follow‐up midcycle TVS imaging showed no ECF. The patient spontaneously conceived 3 months after surgery and achieved a successful pregnancy. The use of a hysteroscopic tissue removal system is a feasible approach to the revision of CSI. Larger studies are necessary in order to determine efficacy for fertility patients.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free